ResearcherJichi Medical UniversityActive in the last 2 years
Junichi Matsubara
Matched on ORCID iD 0000-0003-0116-5133; OpenAlex author ID A5108400667. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 26
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers
Papers 5
- Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatment benefits. Co-author DOI 10.1016/j.pan.2025.04.012↗
- Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery for Resectable Pancreatic Cancer: A Ret… Co-author DOI 10.1245/s10434-025-16956-z↗
- Association between homologous recombination gene variants and efficacy of oxaliplatin-based chemotherapy in advanced pancreatic cancer: prospective multicente… Co-author DOI 10.1007/s12032-023-02011-y↗
- BRCA2 Reversion Mutation Identified by Liquid Biopsy After Durable Response to FOLFIRINOX in BRCA2-Associated Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001672↗
- Reduced plasma level of CXC chemokine ligand 7 in patients with pancreatic cancer. Co-author DOI 10.1158/1055-9965.epi-10-0397↗
Closest collaborators
The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michio Yoshimura · 3 shared papers, 2023–2025 · strength 0.55
- Paper Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatmen… DOI 10.1016/j.pan.2025.04.012↗
- Paper Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery… DOI 10.1245/s10434-025-16956-z↗
- Paper Association between homologous recombination gene variants and efficacy of oxaliplatin-based chemotherapy in advanced p… DOI 10.1007/s12032-023-02011-y↗
- Kei Yamane · 2 shared papers, 2025 · strength 0.41
- Paper Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatmen… DOI 10.1016/j.pan.2025.04.012↗
- Paper Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery… DOI 10.1245/s10434-025-16956-z↗
- Takahiro Iwai · 2 shared papers, 2025 · strength 0.41
- Paper Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatmen… DOI 10.1016/j.pan.2025.04.012↗
- Paper Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery… DOI 10.1245/s10434-025-16956-z↗
- Kazuyuki Nagai · 2 shared papers, 2025 · strength 0.41
- Paper Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatmen… DOI 10.1016/j.pan.2025.04.012↗
- Paper Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery… DOI 10.1245/s10434-025-16956-z↗
- Etsuro Hatano · 2 shared papers, 2025 · strength 0.41
- Paper Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatmen… DOI 10.1016/j.pan.2025.04.012↗
- Paper Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery… DOI 10.1245/s10434-025-16956-z↗
- Akihisa Fukuda · 2 shared papers, 2025 · strength 0.41
- Paper Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatmen… DOI 10.1016/j.pan.2025.04.012↗
- Paper Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery… DOI 10.1245/s10434-025-16956-z↗
- Toshihiko Masui · 2 shared papers, 2023–2025 · strength 0.34
- Paper Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery… DOI 10.1245/s10434-025-16956-z↗
- Paper Association between homologous recombination gene variants and efficacy of oxaliplatin-based chemotherapy in advanced p… DOI 10.1007/s12032-023-02011-y↗
- Tomohiro Kondo · 2 shared papers, 2020–2023 · strength 0.24
- Paper Association between homologous recombination gene variants and efficacy of oxaliplatin-based chemotherapy in advanced p… DOI 10.1007/s12032-023-02011-y↗
- Paper BRCA2 Reversion Mutation Identified by Liquid Biopsy After Durable Response to FOLFIRINOX in BRCA2-Associated Pancreati… DOI 10.1097/mpa.0000000000001672↗
- Manabu Muto · 2 shared papers, 2020–2023 · strength 0.24
- Paper Association between homologous recombination gene variants and efficacy of oxaliplatin-based chemotherapy in advanced p… DOI 10.1007/s12032-023-02011-y↗
- Paper BRCA2 Reversion Mutation Identified by Liquid Biopsy After Durable Response to FOLFIRINOX in BRCA2-Associated Pancreati… DOI 10.1097/mpa.0000000000001672↗
- Masashi Kanai · 2 shared papers, 2020–2023 · strength 0.24
- Paper Association between homologous recombination gene variants and efficacy of oxaliplatin-based chemotherapy in advanced p… DOI 10.1007/s12032-023-02011-y↗
- Paper BRCA2 Reversion Mutation Identified by Liquid Biopsy After Durable Response to FOLFIRINOX in BRCA2-Associated Pancreati… DOI 10.1097/mpa.0000000000001672↗
- Asahi Sato · 1 shared paper, 2025 · strength 0.20
- Toshinao Itani · 1 shared paper, 2023 · strength 0.14
- Tadayuki Kou · 1 shared paper, 2023 · strength 0.14
- Kazuto Nishio · 1 shared paper, 2020 · strength 0.10
- Shoji Nakamori · 1 shared paper, 2011 · strength 0.02
- Michimoto Kobayashi · 1 shared paper, 2011 · strength 0.02
- Tomoo Kosuge · 1 shared paper, 2011 · strength 0.02
- Tsutomu Chiba · 1 shared paper, 2011 · strength 0.02
- Tatsuya Ioka · 1 shared paper, 2011 · strength 0.02
- Naohiro Sata · 1 shared paper, 2011 · strength 0.02
- Yoshinori Tanaka · 1 shared paper, 2011 · strength 0.02
- Akihiko Tsuchida · 1 shared paper, 2011 · strength 0.02
- Tesshi Yamada · 1 shared paper, 2011 · strength 0.02
- Takuji Okusaka · 1 shared paper, 2011 · strength 0.02
- Kazufumi Honda · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.